ALTB-168

· AltruBio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALTB-168, covering 2023-07-06 to 2023-07-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC [Phase 2]

See pricing